Conscientious objection (CO) in healthcare is a controversial topic. Some perceive CO as freedom of conscience, others believe their professional duty-of-care overrides personal-perspectives. There is a paucity of literature pertaining to pharmacists' perspectives on CO. To explore Australian pharmacists' decision-making in complex scenarios around CO and reasons for their choices. A cross-sectional, qualitative questionnaire of pharmacists' perspectives on CO. Vignette-based questions were about scenarios related to medical termination, emergency contraception, IVF surrogacy for a same-sex couple and Voluntary Assisted Dying (VAD) Approximately half of participants ( = 223) believed pharmacists have the right to CO and most agreed to supply prescriptions across all vignettes. However, those who chose not to supply ( = 20.9%), believed it justifiable, even at the risk of patients failing to access treatment. Strong self-reported religiosity had a statistically significant relationship with decisions not to supply for 3 of 4 vignettes. Three emergent themes included: This exploratory study revealed perspectives of Australian pharmacists about a lack of guidance around CO in pharmacy. Findings highlighted the need for future research to investigate and develop further training and professional frameworks articulating steps to guide pharmacists around CO.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10989204 | PMC |
http://dx.doi.org/10.1080/20523211.2024.2323086 | DOI Listing |
Front Pharmacol
January 2025
Department of Pharmaceutical Management and Marketing, Faculty of Pharmacy, University of Medicine and Pharmacy of Craiova, Craiova, Romania.
Introduction: Pharmacy-based vaccination services are now available in 56 countries, including Romania, that started administering the flu-vaccines in the community pharmacies from 2022. Assessing how pharmacists managed this new pharmaceutical service in Romania is the subject of this study.
Methods: A cross-sectional study was conducted among all the pharmacies from Romania that were authorized to provide this service (442 pharmacies, from which 53 were in rural areas).
Int J Pharm Pract
January 2025
Pharmacy Department, Gold Coast Health, Southport, Queensland 4215, Australia.
Objectives: This study explored South-East Queensland Australian pharmacists' perspectives on preparing discharge medicine lists, specifically involvement of pharmacy assistants, use of electronic medication management software, and expanding pharmacists' scope during discharge.
Methods: Electronic survey distributed to pharmacists during December 2021 and data collected over 3 weeks.
Key Findings: Pharmacists supported increased involvement of pharmacy assistants (with structured collaborative training), pharmacist-led medication reconciliation, and producing the discharge medicine list directly from the electronic record.
Front Med (Lausanne)
January 2025
Department of Pharmacy Practice, College of Clinical Pharmacy, King Faisal University, Al-Ahsa, Saudi Arabia.
Background: Community pharmacists are most accessible to patients. Hence, they have a crucial role in ensuring drug safety by detecting and reporting adverse drug reactions (ADRs). However, there may be gaps in their knowledge of ADR reporting systems and barriers they face in reporting.
View Article and Find Full Text PDFBMJ Open
January 2025
Department of Pharmaceutical Sciences, University of Sorocaba, Sorocaba, Brazil
Objective: To map instruments for assessing healthcare professionals' knowledge, attitudes and practices regarding deprescribing.
Introduction: Deprescribing is essential for improving patient outcomes by managing polypharmacy, reducing fall risks and decreasing medication costs. However, there is a limited exploration of healthcare professionals' perspectives about deprescribing.
BMJ Open
January 2025
Oriola Finland Oy, Espoo, Uusimaa, Finland
Background: The use of new biological medicines as standard treatment is expected to increase substantially and cover new therapeutic indications in the near future. Interchange of biological medicines in pharmacies increases the need for patient guidance.
Objectives: The study aims to gain a patient perspective on biological medicine users' needs and wishes regarding patient guidance by exploring what kind of information patients wish to receive and to further investigate the potential differences in needs between originator biological medicine users and biosimilar users.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!